Page 2 - John Corboy News Today

Highlight of the Week It’s that time of the summer: The La Plata County Fair starts today and runs through Sunday. And as with every year, the fair offers a large variety of events – the Demolition De...

Highlight of the week VFW Post 4031 hosts a comedy night featuring Jody Fuller and supported by Durango comics from Comic Uprising at 6 p.m. Saturday at the post, 1550 Main Ave. Fuller is a comic, spe...

DISCOMS trial looks at whether MS patients should stop treatment as they age

Does MS cause pain? Should people with MS exercise? Many common beliefs about MS aren’t true, but here we separate fact from fiction.

Researchers have found strong evidence that infection with the Epstein-Barr virus, best known for causing mononucleosis, triggers MS.

How this relates to infection outcomes or risk of infecting others is unknown

To treat or not to treat? I’ve been treated with four DMTs in my four decades of living with MS. The first was Avonex (interferon beta 1a) in 1996. Then came Tysabri (natalizumab) and Aubagio (teriflunomide). The most recent was Lemtrada (alemtuzumab) in late 2016. I believe Lemtrada was the most effective of the four, and I was 68 when this treatment began. Lemtrada halted my progression and improved some of my symptoms. But some neurologists won’t prescribe a DMT for someone older than 50...

email article Antibody responses after SARS-CoV-2 infection were reduced in multiple sclerosis (MS) patients on ocrelizumab (Ocrevus) compared with other MS patients, but T-cell responses were not, preliminary data from a New York study suggested. Antibody detection varied but T-cell levels were similar for patients with COVID-19 and MS regardless of the disease-modifying treatment they used, reported Ilya Kister, MD, of NYU Langone Health in New York City, at the Emerging Science session...